Central nervous system (CNS) lymphoma is a rare non-Hodgkin lymphoma in which malignant B cells from lymph tissue form in the brain and/or spinal cord or spread from other parts of the body to the ...

Incyte's Monjuvi as part of a multi-drug regimen that includes a chemotherapy standard of care for an aggressive form of non-Hodgkin lymphoma reduced the risk of ...

A blood test following CAR T-cell therapy for relapsed/refractory mantle cell lymphoma (MCL) appears to do a better job than PET-CT scans at predicting which patients have poor prognoses, a small, ...

St. David's South Austin enrolled the first patient in a global lymphoma therapy study using a next-generation CAR T approach ...

When mantle cell lymphoma stops responding to treatment, the options narrow fast. This rare but aggressive form of ...

Doctors monitor lymphocyte and other blood cell levels to predict how your lymphoma will progress. Low lymphocyte counts may suggest that cancer has spread to your bone marrow, or it can be a side ...

Circulating tumor DNA found in blood plasma may help predict if the likelihood of relapse for patients with large B-cell lymphoma, according to recent research. With next-generation sequencing, ...

Researchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targeted treatments for some blood cancer patients. The cancer ...

Dr. Kathleen Elliott says blood cancers can impact the health, function and production of blood. Blood transfusions are a ...

Multiple myeloma (MM) and lymphoma are both cancers that affect cells in a person’s blood. MM is a cancer of plasma cells, while lymphoma is a cancer of lymphocytes. Both plasma cells and lymphocytes ...

Thymic lymphoma is a type of blood cancer. It happens when white blood cells called lymphocytes become cancerous. These types of blood cells come from the thymus gland, which sits behind your ...